ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.38
0.74%
US Tech 100
20,836.00
1.31%
S&P 500
5,930.85
1.09%
US Dollar vs CAD
1.43421
0.00%
Bitcoin
96,535.02
-0.70%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Aura Biosciences Inc (AURA) Share Price

Aura Biosciences Inc

Aura Biosciences Inc (AURA)

Aura Energy Limited
8.20
0.09
(1.11%)
Closed December 21 3:00PM
Delayed by 15 minutes
8.2005
0.0005
(0.01%)
After Hours: 6:59PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
8.20
Bid
7.12
Ask
13.20
Volume
612,493
8.01 Day's Range 8.43
6.63 52 Week Range 12.3782
Market Cap
409.602M
Previous Close
8.11
Open
8.03
Last Trade
623
@
8.2
(priorref)
Last Trade Time
Financial Volume
US$ 4,982,809
VWAP
8.1353
Average Volume (3m)
202,202
Shares Outstanding
49,951,466
Dividend Yield
-
PE Ratio
-5.37
Earnings Per Share (EPS)
-1.53
Revenue
-
Net Profit
-76.41M

About Aura Biosciences Inc

Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long-lasting anti-tumor immunity. Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long-lasting anti-tumor immunity.

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.aurabiosciences.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Aura Biosciences Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker AURA. The last closing price for Aura Biosciences was US$8.11. Over the last year, Aura Biosciences shares have traded in a share price range of US$ 6.63 to US$ 12.3782.

Aura Biosciences currently has 49,951,466 shares outstanding. The market capitalization of Aura Biosciences is US$405.11 million. Aura Biosciences has a price to earnings ratio (PE ratio) of -5.37.

Ask ADVFN Intelligence (AI)

AURA Latest News

More News

Aura Biosciences to Participate in the 7th Annual Evercore ISI HealthCONx Conference

BOSTON, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ...

November 26 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

November 18 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

November 18 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

November 14 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

November 12 2024
Edgar (US Regulatory)

Form 8-K - Current report

November 12 2024
Edgar (US Regulatory)

Aura Biosciences Reports Third Quarter 2024 Financial Results and Business Highlights

Positive Phase 2 End of Study Data with Bel-sar in Early-Stage Choroidal Melanoma; Ongoing Phase 3 CoMpass Trial Recently Received Authorization to Start Enrolling Patients in Europe Multiple...

November 12 2024
GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

November 08 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

October 29 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

October 29 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.18-2.147971360388.389.048.0252151628.47804317CS
4-0.82-9.090909090919.029.538.0251924678.70404999CS
12-0.96-10.4803493459.1612.37828.0252022029.77877856CS
261.1315.98302687417.0712.37826.631920409.14070888CS
52-0.55-6.285714285718.7512.37826.631791878.52910211CS
156-7.17-46.64931685115.3724.835.9912359410.15983231CS
260-5.9-41.843971631214.126.165.9912688810.66362821CS

AURA - Frequently Asked Questions (FAQ)

What is the current Aura Biosciences share price?
The current share price of Aura Biosciences is US$ 8.20
How many Aura Biosciences shares are in issue?
Aura Biosciences has 49,951,466 shares in issue
What is the market cap of Aura Biosciences?
The market capitalisation of Aura Biosciences is USD 405.11M
What is the 1 year trading range for Aura Biosciences share price?
Aura Biosciences has traded in the range of US$ 6.63 to US$ 12.3782 during the past year
What is the PE ratio of Aura Biosciences?
The price to earnings ratio of Aura Biosciences is -5.37
What is the reporting currency for Aura Biosciences?
Aura Biosciences reports financial results in USD
What is the latest annual profit for Aura Biosciences?
The latest annual profit of Aura Biosciences is USD -76.41M
What is the registered address of Aura Biosciences?
The registered address for Aura Biosciences is CORPORATION TRUST CENTER, 1209 ORANGE ST, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Aura Biosciences website address?
The website address for Aura Biosciences is www.aurabiosciences.com
Which industry sector does Aura Biosciences operate in?
Aura Biosciences operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MYSZMy Size Inc
US$ 4.2001
(211.12%)
121.03M
NVNINVNI Group Ltd
US$ 8.26
(209.36%)
78.06M
TPICTPI Composites Inc
US$ 2.45
(100.82%)
34M
ICGIntchains Group Ltd
US$ 8.77
(88.60%)
527.94k
HSDTHelius Medical Technologies Inc
US$ 0.884851
(84.34%)
121.95M
CYNCYNGN Inc
US$ 0.4603
(-71.41%)
27.91M
MTEMMolecular Templates Inc
US$ 0.1502
(-57.09%)
8.75M
PRFXPainReform Ltd
US$ 5.15
(-53.85%)
2.94M
GALTGalectin Therapeutics Inc
US$ 1.03
(-48.50%)
9.27M
BCABBioAtla Inc
US$ 0.6923
(-41.82%)
6.25M
EDBLEdible Garden AG Inc
US$ 0.24
(65.06%)
354.33M
NVDANVIDIA Corporation
US$ 134.70
(3.08%)
310.19M
APTOAptose Biosciences Inc
US$ 0.28
(64.51%)
306.25M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.606999
(6.49%)
293.22M
PLTRPalantir Technologies Inc
US$ 80.55
(8.54%)
281.23M

Discussion

View Full Feed
ron_66271 ron_66271 3 minutes ago
Edit; $500 Billion was sold to F&F.
COOP
janice shell janice shell 3 minutes ago
He's probably forgotten all about our extraordinarily warm autumn as well.
Preciouslife1 Preciouslife1 3 minutes ago
https://www.mlb.com/news/mlb-reacts-to-rickey-henderson-passing
firebag1 firebag1 4 minutes ago
Yeah lol so would I!!!
HMBL
hookrider hookrider 4 minutes ago
sortagreen: "alcohol or dog treats} Works for me!!!
blackhawks blackhawks 7 minutes ago
More frequent and more intense storms are effects of climate change. Can you recall any of those from this past summer?
investisseur101 investisseur101 7 minutes ago
Yes all is possible like $

The better way is to keep your shares when they stay above Sma50..its safe because its the phase2 (bullish phase)

But i like to follow targets and long-term trends to know resistance and follow the SMA50 as support. This way I can trade and se
HMBL
carlson carlson 7 minutes ago
Happy Holidays!!!
NBRI
RobotDroid RobotDroid 9 minutes ago
A fool on a sinking ship.
NWBO
blackhawks blackhawks 10 minutes ago
Trump2 will begin with a deportation and trade war inducing recession that may rival the 'Great One'. If it drags on into '26 the midterms will make Trump not just a lame duck but a dead one.
Tr8dervic Tr8dervic 10 minutes ago
Rec'd $25 from Nadine. Thank you!

** Current Players (( AND YOUR Number OF PLAYS )) **

************************************************************************************************

Tr8dervic ( 09 ) Plays C5

ElisGone ( 04 ) Plays C5
firebag1 firebag1 12 minutes ago
Yeah I would say this is ready for blast offfffff
TNXP
D-Mike D-Mike 12 minutes ago
Most undervalued stock in the market. We should be $2-$3 bil MC right now ($25 to $35 per share). IMHO
AVXL
firebag1 firebag1 12 minutes ago
That’s fruckking awesome!!!!
TNXP
gitreal gitreal 13 minutes ago
No one referenced "shorty"? Not true. The comment was "One thing for certain, don't believe in Short BS." That tells me that he believes that NBRI is being shorted, and that bashers are just here to support that shorting. Every crappy OTC stock is being shorted massively, right? By evil, corru
NBRI
janice shell janice shell 13 minutes ago
This is how our hero was looking yesterday:

https://x.com/ronfilipkowski/status/1870587703265513851?s=42

Seems to have been babbling. Looks as if he forgot his makeup.
gfp927z gfp927z 15 minutes ago
Bar, OT - >> S+P 500
VOO
BDEZ BDEZ 16 minutes ago
XRP
blackhawks blackhawks 16 minutes ago
What is it going to take for you to comprehend the refutations of what you claim? Recognition Lag can't account for the 'startlingly big difference'. And the rest of the arguments in my posts blow your arguments out of the water.

Do you really think that the authors are unaware of rec
BDEZ BDEZ 17 minutes ago
SHIB
BDEZ BDEZ 17 minutes ago
DOGE
BDEZ BDEZ 17 minutes ago
BTC
doc2016 doc2016 17 minutes ago
news this weekend meta is partnering with oracle cloud to save money?
maybe zuck talked to some vcsy people or msft about m teams and maybe using ploinks/puddle via 8 versus msft telephony? oracle and netsuite are 8 partners, i've been wondering why now that oracle has their own cloud? or ,

Your Recent History

NASDAQ
AURA
Aura Biosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads